Myelotib 150mg Tablet

Myelotib 150mg Tablet is an antineoplastic drug containing nilotinib, a tyrosine kinase inhibitor. It is used to treat Philadelphia chromosome-positive chronic myeloid leukaemia (Ph-positive CML) in adults and paediatric patients. Treatment is indicated in patients newly diagnosed with chronic myeloid leukaemia (CML) and in those who have experienced adverse effects from prior therapy. It is also used in patients with CML that no longer responds to previous treatment including imatinib.

Do not take this medicine if you are allergic to nilotinib or any other ingredients in this formulation. Inform your doctor if you have a history of cardiac conditions including myocardial infarction, cardiac arrhythmias, chest pain, cerebrovascular accident, or claudication. Notify your doctor of any liver or pancreatic disorders, or deficiencies in potassium or magnesium. Disclose all current medications to your doctor, particularly those used to manage cholesterol levels. Inform your doctor of any history of hepatitis B infection, as this medicine may reactivate hepatitis B, which can be serious in some cases. Avoid consumption of grapefruit and grapefruit juice. If you have lactose intolerance or sugar malabsorption, inform your doctor before starting treatment.

During treatment with Myelotib 150mg Tablet, your doctor may order regular blood tests to monitor liver and pancreatic function, blood cell counts including white blood cells, red blood cells, and platelets. Cardiac monitoring including QT interval assessment, electrolyte levels, and glucose and lipid profiles will be conducted to assess tolerance to the medication. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding. Use effective contraception during treatment with this medicine.

Blood cancer (Philadelphia chromosome-positive chronic myeloid leukemia) in adults and paediatrics.

BCR-ABL tyrosine kinase is responsible for the uncontrolled division of cells in the CML. Myelotib 150mg Tablet disrupts the signaling route of the protein kinase enzyme which targets the BCR-ABL protein and inhibits the growth and spread of cancer cells.

Take Myelotib 150mg Tablet as advised by your physician. Swallow the medicine with a glass of water. Do not crush, chew, or open the medicine. Your doctor will decide the correct dose and duration for you based on your age, body weight, and disease condition. Do not stop taking Myelotib 150mg Tablet unless your doctor advises you to stop.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Sudden weight gain Swelling in hands, feet, ankles, or face Chest pain Blood pressure (high and low) Discoloration of tongue, lips, or skin (blue) Abnormal heart (irregular heartbeat) Hair loss Vision problem Stomach pain, vomiting of blood, blood in stools. Yellowing of the skin, eyes, and dark urine. High blood sugar levels. Sensitivity to light Common Nausea, vomiting, diarrhoea. Headache, muscle pain, stomach pain. Hair loss. Tiredness. Constipation. Slowing of growth in children. Pneumonia. Loss of appetite. Sleeplessness, depression, and anxiety. Stomach discomforts like bloating and flatulence after meals. musculoskeletal pain

Based on your condition your doctor may prescribe a lower dose. Myelotib 150mg Tablet can be used by people aged 65 years and over with the same dose as other adults. Tell your doctor if you experience any irregular heartbeats or any signs of a heart condition because this can lead to serious complications like sudden death. Inform your physician if you have kidney problems. Your physician will decide whether you may receive this medication after monitoring your kidney functions. Some children and adolescents taking this medicine may have slower than normal growth. So, your doctor will regularly monitor your growth. Report to your doctor if you have had a history of heart failure or hepatitis infection. Discuss effective contraceptive options with your healthcare provider.